Posts by: Ashraf Malhas

News

Ofev, an approved therapy for idiopathic pulmonary fibrosis (IPF), can prevent the progression of squamous cell carcinoma in the lungs associated with IPF, a case study reports. The study, “Nintedanib ... Read more

August 16, 2018August 20, 2018

Extracellular Vesicles Likely Play Role in IPF Development, Study Reports

News

Tiny extracellular vesicles that carry information from one cell to another may contribute to the development of idiopathic pulmonary fibrosis (IPF) by carrying molecules involved in the disease, a study has ... Read more

August 10, 2018August 16, 2018

Study Offers Molecular Insights into Structural Changes that Occur in Lungs of IPF Patients

News

A recent study has provided more insight into the molecular processes that might be involved in the pathological changes that take place in the lungs of patients with idiopathic pulmonary fibrosis ... Read more